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In September 2010, a cholera outbreak was reported from Odisha, Eastern India. V. cholerae isolated from the clinical
samples were biochemically and serologically confirmed as serogroup O1, biotype El Tor, and serotype Ogawa. Multiplex PCR
screening revealed the presence of various genes, namely, ompW, ctxB, zot, rfbO1, tcp, ace, hlyA, ompU, rtx, and toxR, in
all of the isolates. The isolates were resistant to co-trimoxazole, nalidixic acid, polymyxin B, spectinomycin, streptomycin,
sulfamethoxazole, tetracycline, trimethoprim, and vibriostatic agent 2,4-diamino-6,7-diisopropylpteridine (O/129). Minimum
inhibitory concentration of tetracycline decreased in the presence of carbonyl cyanide m-chlorophenylhydrazone (CCCP),
suggesting the involvement of efflux pumps. PCR analysis confirmed the presence of class I integrons as well as SXT elements
harbouring antibiotic resistance genes in all isolates. Sequencing revealed the presence of ctxB gene of classical biotype in all the
isolates. The isolates harboured an RS1-CTX prophage array with El Tor type rstR and classical ctxB on the large chromosome.The
study indicated that the V. cholerae El Tor variants are evolving in the area with better antibiotic resistance and virulence potential.
1. Introduction
Cholera is still a major health problem of global importance
as evidenced by the recent outbreaks in Haiti and Zimbabwe.
In 2013, a total of 47 countries from all continents reported
129 064 cases of cholera including 2102 deaths with a case
fatality rate of 1.63% [1]. Toxigenic Vibrio cholerae, the
causative agent of cholera, has exhibited several changing
patterns in its biotype aswell as in drug resistance for its better
survival and infection [2, 3]. Classical biotype V. cholerae
strains after causing earlier six cholera pandemics were
replaced by El Tor biotype strains in the seventh pandemic.
The variant of V. cholerae El Tor strain possessing cholera
toxin of classical biotype appeared after the emergence
of O139 strain and has now become prevalent worldwide
[4]. Antimicrobial susceptibility pattern has continuously
changed for V. cholerae [2]. Tetracycline is an important
broad spectrum antibiotic used for the prophylaxis and
treatment of variety of bacterial infections including listed
biothreat agents Bacillus anthracis, Francisella tularensis, and
Yersinia pestis [5]. It has been a preferred choice for control of
cholera as recommended byWHO [6]. Earlier, we reported a
novel mutation in ctxB gene of outbreak isolates in 2007 from
Rayagada (19.09∘N 83.27∘E), Odisha, and later on the same
allelic variation was observed in the Haitian outbreak isolates
[7, 8]. These isolates were multidrug resistant but sensitive
to tetracycline [8]. In September-October, 2010, another
cholera outbreak was observed in the same area of Rayagada,
Odisha. In this communication, we report the emergence of
tetracycline resistantV. cholerae from this outbreak of Eastern
India.
2. Materials and Methods
2.1. Isolation and Identification of V. cholerae. A total of 27
V. cholerae isolates were recovered from randomly selected
patients during the cholera outbreak in themonth of Septem-
ber, 2010, fromRayagada district of Odisha (19.09∘N83.27∘E).
Samples were collected using sterile rectal swabs from the
patients and processed as described earlier [9]. V. cholerae
isolates were identified and confirmed by using standard bio-
chemical methods. Serological identification of the isolates
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was done by slide agglutination using commercially available
polyvalent antiserum against V. cholerae O1 (Difco, USA).
Voges Proskauer (VP) test, sheep erythrocyte haemolysis,
and polymyxin B susceptibility tests were performed for
determination of biotype of isolates. Other bacterial reference
strains used in the study were V. cholerae O1 El Tor (ATCC
14033), V. choleraeO1 classical (ATCC 11623), and V. cholerae
O139 (ATCC 51394).
2.2. PCR Assays for Virulence and Species-Specific Genes.
Genomic DNA was extracted from each of the isolates using
genomic DNA purification kit (MBI Fermentas, Vilnius,
Lithuania) and screened for the presence of diverse gene traits
by two sets of multiplex PCR (mPCR) as described elsewhere
[10].The first mPCR detected the presence of genes encoding
the outer-membrane protein (ompW), cholera toxin (ctxB),
zonula occludens toxin (zot), O1 somatic antigen (rfbO1), and
toxin coregulated pilus (tcp). The second mPCR amplified
other virulence and toxigenic genes encoding the acces-
sory cholera enterotoxin (ace), haemolysin (hlyA), outer-
membrane protein (ompU), repeat in toxin protein (rtx), and
toxin regulator (toxR).
2.3. Antimicrobial Drug-Susceptibility Testing. The antimi-
crobial susceptibility of the V. cholerae isolates was deter-
mined by the Kirby-Bauer disc diffusionmethod onMueller-
Hinton agar [11], and minimum inhibitory concentration
(MIC) was calculated by broth dilution method according
to the guidelines of Clinical Laboratory Standards Insti-
tute [12]. The antibiotic discs and antibiotic powder were
procured from Oxoid limited, UK, and Sigma Aldrich,
USA, respectively. The antibiotic discs used were ampicillin
(10 𝜇g), chloramphenicol (30 𝜇g), ciprofloxacin (5 𝜇g), co-
trimoxazole (25𝜇g), erythromycin (10 𝜇g), nalidixic acid
(30 𝜇g), polymyxin B (50𝜇g), rifampicin (5 𝜇g), spectino-
mycin (100 𝜇g), streptomycin (10 𝜇g), sulphamethoxazole
(100 𝜇g), tetracycline (30 𝜇g), trimethoprim (5𝜇g), and vib-
riostatic agent 2,4-diamino-6,7-diisopropylpteridine, O/129
(150 𝜇g). The MIC for selected antibiotics was calculated in
the presence of carbonyl cyanide m-chlorophenylhydrazone
(CCCP) at subinhibitory concentration. Reference strains of
Escherichia coli ATCC 25922, Staphylococcus aureus ATCC
25923, and Pseudomonas aeruginosa ATCC 27853 were used
in each test for internal quality control.
2.4. Mobile Genetic Elements and Their Gene Cassettes. The
presence of class 1 integron and SXT constins was detected
by PCR as described by Hochhut et al. [13]. The presence
of gene cassettes for aadA2 (encoding resistance for strep-
tomycin and spectinomycin), strA (encoding resistance for
streptomycin), blaP1 (encoding resistance for 𝛽-lactams),
floR (encoding resistance for chloramphenicol), and dfrA1
(encoding resistance for trimethoprim) was determined by
PCR as described earlier [14, 15].
2.5. Sequencing of the ctxBGene. The ctxB gene was amplified
from the isolates using primers described previously [16].
Sequencing was carried out using the same PCR primers
on a 96-capillary model 3730xl system using the Big Dye
Terminator kit from Applied Biosystems (Applied Biosys-
tems, Foster City, CA, USA). The sequences were edited with
SeqED program (Applied Biosystems) and were aligned with
sequences of ctxB gene of reference strains ofV. choleraeO1 El
Tor, classical, and O139. The deduced amino acid sequences
of the ctxB gene from all the strains were aligned using
CLUSTALW.
2.6. Analysis of RS1 and CTX Prophage Array. Arrangement
of RS1 and CTX phage was determined by PCR. Presence
of the RS1 element was confirmed by PCR using the rstC
specific primers as described elsewhere [17]. The primers
for 𝑟𝑠𝑡𝑅El Tor, 𝑟𝑠𝑡𝑅Classical, and 𝑟𝑠𝑡𝑅Calcutta were used for rstR
typing of RS element and for differentiation of classical and
El Tor biotype of V. cholerae [18]. The location of an RS1-
CTX prophage array on the large chromosome, insertion of
the CTX prophage on the small chromosome, and tandem
repeats of RS1 and CTX prophage on chromosome were
determined by PCR as described earlier [17].
3. Results
3.1. Identification of Outbreak Strains. A total of 27 clinical
strains of V. cholerae were isolated from the affected patients
during cholera outbreak in Odisha, Eastern India. On the
basis of biochemical tests, all the isolates were found to
belong to El Tor biotype as the isolates were VP test positive,
hemolytic on sheep blood agar, and resistant to polymyxin B.
3.2. Gene Traits. Two sets of multiplex PCR revealed that all
the outbreak isolates were invariably positive for various vir-
ulent and species-specific genes, namely, ace (309 bp), ctxAB
(536 bp), hlyA (480 bp), ompU (655 bp), ompW (304 bp),
rfbO1 (638 bp), rtxC (265 bp), tcpA (805 bp), toxR (779 bp),
and zot (947 bp) genes (Table 1).
3.3. Antibiotic Drug Resistance Pattern. The antimicrobial
disc diffusion test revealed that all the isolates were
resistant to co-trimoxazole, nalidixic acid, polymyxin B,
spectinomycin, streptomycin, sulfamethoxazole, tetracycline,
trimethoprim, and vibriostatic agent 2,4-diamino-6,7-
diisopropylpteridine (O/129). However, the isolates were
sensitive to ampicillin, chloramphenicol, erythromycin,
ciprofloxacin, and rifampicin. The MIC for selected
antibiotics is given in Table 2. The presence of carbonyl
cyanide m-chlorophenylhydrazone (CCCP), an inhibitor
of major facilitator superfamily (MFS) proteins in broth at
subinhibitory concentration (0.5 𝜇g/mL), reduced MIC for
tetracycline to eightfold (16 to 2𝜇g/mL) and the isolates
became susceptible. CCCP also reduced the MIC for
trimethoprim from 1024𝜇g/mL to 256𝜇g/mL, whereas
MIC for nalidixic acid, streptomycin, sulfamethoxazole, and
ampicillin remained unaffected (Table 2).
3.4. Prevalence ofMultidrug Resistant Elements. PCR analysis
revealed the presence of class I integron as well as SXT ele-
ment harbouring antibiotic resistance traits against multiple
drugs in all the isolates. The isolates were positive for aadA2
(streptomycin and spectinomycin) and dfrA1 (trimethoprim)
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2007 O1 El TorOgawa
ompW+, ctxB+, zot+, rfbO1+,
tcp+, ace+, hlyA+, ompU+,
rtx+, and toxR+
CotR, NalR, PolR, SpeR, StrS,
SulR, TriR, AmpR, TetS, ChlS,
EryR. CipS, and RifS
+ + aadA2
+, blaP1−, dfrA1+,
floR−, and strA+ [10, 19]
2010 O1 El TorOgawa
ompW+, ctxB+, zot+, rfbO1+,
tcp+, ace+, hlyA+, ompU+,
rtx+, and toxR+
CotR, NalR, PolR, SpeR, StrR,
SulR, TetR, TriR, O/129R,




floR−, and strA+ This study
Cot: co-trimoxazole, Nal: nalidixic acid, Pol: polymyxin B, Spe: spectinomycin, Str: streptomycin, Sul: sulfamethoxazole, Tet: tetracycline, Tri: trimethoprim,
Amp: ampicillin, and Ery: erythromycin.
Table 2: Effect of CCCP on minimum inhibitory concentration (MIC) of various antibiotics on V. cholerae isolates.
Isolate Tet Nal Str Sul Tri Amp
(𝜇g/mL) (𝜇g/mL) (𝜇g/mL) (𝜇g/mL) (𝜇g/mL) (𝜇g/mL)
VCR4 16 32 ≥1024 ≥4096 ≥1024 4
VCR4 + CCCP 2 32 ≥1024 ≥4096 256 4
gene cassettes but negative for blaP1 (𝛽-lactam antibiotics)
cassettes [14].The strainswere also positive for strA carried on
SXT constin that confers resistance for streptomycin. How-
ever, all the isolates were negative for floR (chloramphenicol)
genes.
3.5. Sequence Analysis of ctxB. The deduced amino acid
sequence analysis of CT-B from the representative isolates
varied from CT-B of reference El Tor strain N16961 and
O139 strain at position 39 (histidine in place of tyrosine)
and position 68 (threonine in place of isoleucine) but was
similar to CT-B subunit of reference classical strains 569B
(Figure 1). However, nomutationwas observed at position 20,
which was found in the V. cholerae isolates from the previous
outbreak in 2007 (Figure 1).
3.6. Phage Array. The cholera toxin gene ctxAB lies on the
single stranded DNA of CTX phage which is a filamentous
phage [20].There is specific site for integration of CTX phage
DNA into the V. cholerae chromosome. Toxigenic strains
contain a genetic element RS1 which is related to CTX phage.
RS1 element is found adjacent (5󸀠 or 3󸀠) to CTX prophage.
Several types of CTXphage/RS1 arrays have been found in the
epidemic V. cholerae strains [21]. In this study, rstC specific
primer set rstCF/rstCR amplified the DNA, indicating the
presence of the RS1 element in the chromosome.APCRprod-
uct was amplified with rstCF/cepR showing the existence of
RS1-CTXprophage array. In contrast, ctxBF and rstCR primer
pair did not give any amplification, indicating the absence of
CTX prophage-RS1 array. No DNA fragment was amplified
using the primer pairs of ctxBF/cepR and rstCF4/rstCR4,
indicating the absence of tandem repeats of CTX prophage
andRS1 element on the genome, respectively. Location of RS1-
CTXprophage array on the large chromosomewas confirmed
with the PCR amplified products using Ch1F/rstAR and
ctxBF/Ch1R primers.The isolates yielded PCRproducts using
Ch2F/Ch2R primers indicating the absence of the CTX
prophage or RS1 element on small chromosome. The RS1-
CTX prophage array has been shown in Figure 2.
4. Discussion
V. cholerae O1 El Tor strains are supposed to have better
adaptability in the environment and colonize more efficiently
in the intestinal lumen as compared to the classical one [22].
However, cholera toxin of classical type causes greater fluid
accumulation in the intestinal lumen as compared to toxin
of El Tor type [23]. Therefore, hybrid biotype property of V.
cholerae enhances the infection potential and adaptability in
the environment showing their epidemiological successful-
ness. Outbreaks of such variant type strains are associated
withmore fluid loss and increased case fatality rate [24]. It has
now become a global threat as most of the outbreak strains
are associated with variant El Tor strains in India and other
countries [3, 7, 16].
All isolates from this outbreak were identified as V.
cholerae O1 biotype El Tor serotype Ogawa. The isolates
harboured various toxigenic and pathogenic genes (Table 1).
The presence of ompW, ctxB, and rfbO1 genes confirmed the
V. cholerae species, its toxigenicity, and group 1 antigen of the
“O” side chain of the LPS (serogroup), respectively. Presence
of rtxA or rtxC genes determines the biotypes of V. cholerae
O1 [25, 26]. All isolates in this study belonged to the El Tor
biotype on the basis of the repeat in toxin gene (rtxC).
Sequencing of ctxB gene revealed that all V. cholerae O1
El Tor isolates in this study had ctxB sequence of the classical
biotype. Classical biotype strains were replaced by the El
Tor biotype in the seventh and current pandemic of cholera.
Both biotypes of V. cholerae O1 are closely related in their O-
antigen biosynthetic genes. However, the genomic structure
of the CTXΦ, in which the cholera toxin genes are contained,
differs between the classical and El Tor biotypes [20, 27]. On
the basis of genetic structures of the CTX prophage and RS1
element on each chromosome, atypical El tor strains have
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N16961 El Tor reference NC-002505
V. cholerae O139 X76391)
569B Classical reference U25679
VCO17 El Tor from Dhaka DQ523221
VCO73 El Tor from Dhaka DQ523222
KSJ03 El Tor EU156475
VCC1588 El Tor from Chennai EU428013
VCC5910 El Tor from Chennai EU428018
VOC4 El Tor from Orissa EU496273
VOC6 El Tor from Orissa EU496274
VOC50 El Tor from Orissa EU496278
VCR4 El Tor from Odisha JX846970
VCR5 El Tor from Odisha JX846971
VCR6 El Tor from Odisha JX846972
VCR7 El Tor from Odisha JX846973
VCR8 El Tor from Odisha JX846974

















Figure 1: Amino acid sequence alignment of CTB subunit of V. cholerae O1 El Tor isolates from Odisha outbreak with preexisting reference
El Tor and classical strains. Identical amino acid residues are indicated by dots. Amino acid sequences of V. cholerae CTB used in alignment





1 El Tor CTX prophage with classical ctxB
rstRET rstRETrstA rstArstB rstBrstC cep orfU ace zot ctxA ctxBcla
Figure 2: Genetic structures and CTX prophage array of V. cholerae strains. Block arrows indicate the transcription direction of each gene.
Black triangles on the genome indicate the repeat sequence flanking the integrated phage DNA. V. cholerae isolates in this study contain a
single RS1 element and a single classical CTX prophage after the TLC element on chromosome I.
been classified into two different groups [17, 28]. Group 1
strains harbor a tandem repeat of the classical CTX prophage
on the small chromosome and Group II strains contain the
RS1 and CTX prophage with El Tor type rstR and classical
ctxB on the large chromosome [28, 29]. All the strains used
in this study belonged to Group II and contained the RS1 and
CTX prophage with El Tor type rstR and classical ctxB on the
large chromosome.
Odisha is situated at the coast of Bay of Bengal and in
general outbreaks in the state are linked to flooding and
cyclones [10, 30]. The variant El Tor strains are circulating
in Odisha since 2000 and appeared in Rayagada district in
2002 but the first outbreak due to this strain was recorded in
2007 [10, 31]. To the best of our knowledge, this was the first
time when tetracycline resistant clone of variant El Tor strain
caused an outbreak in Odisha. Recently, tetracycline resistant
V. cholerae strains have been reported from several other parts
of India [32, 33]. Tetracycline has been a drug of choice for
control of severe cases of cholera [6].Therefore, resistance for
tetracycline further curtails the list of cost effective first-line
drugs for control of cholera.
All the Vibrio cholerae isolates in this study harboured
class 1 integron and SXT constins. In this region, qacEΔ1
and sul1 genes provide resistance to ammonium compounds
and sulphonamides, respectively. All the isolateswere positive
for aadA2 and dfrA1 genes, which confer resistance to
streptomycin and trimethoprim, respectively. However, all
the isolates were PCRnegative for blaP1 involved in resistance
for 𝛽-lactam antibiotics (Table 1). The SXT constin is a
conjugative, self-transmissible, and integrative element that
provides resistance to sulphamethoxazole, trimethoprim,
chloramphenicol, and streptomycin. In this study, all isolates
were susceptible to chloramphenicol and PCR negative for
floR gene. In addition, the gene for streptomycin resistance
(strA) was invariably present in all the isolates.
Integrons provide natural genetic engineering platforms
that incorporate gene cassettes and convert them to func-
tional genes by ensuring correct expression in bacteria.
The present study showed that now V. cholerae outbreak
strains carry the mobile antibiotic genetic elements and the
horizontal transfer of these genes is the major cause of
emergence of multidrug resistance strains. The commonly
prescribed antibiotics in India for the treatment of diarrhea
are fluoroquinolones (DNA damaging drugs) that induce
horizontal transfer of SXT elements leading to inter- and
intraspecies spread of multidrug resistance [34]. Therefore,
use of such drugs should be closely monitored as most of the
recent outbreak strains carry these elements [16, 19, 35].
MIC of tetracycline decreased eightfold in the presence
of CCCP, indicating the role of efflux pumps in tetracy-
cline resistance [36]. However, the MIC for nalidixic acid
(32 𝜇g/mL) remained unaffected in the presence of CCCP
indicating the involvement of some other mechanisms also
for antibiotic resistance. Tetracycline resistance in Gram neg-
ative bacteria occurs due to the acquisition of genes encoding
efflux pump and ribosomal protection proteins. Most of the
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efflux pumps belong to major facilitator superfamily (MFS),
which export tetracycline from the cell and exchange a
proton against the concentration gradient [37]. The isolates
from this outbreak were PCR negative for the reported
ribosomal protection protein Tet(M) in Vibrios (data not
shown). Efflux mediated tetracycline resistance (tet genes)
in Vibrios is mostly characterized in non-V. cholerae species
[37]. Therefore, the detailed investigation of the mechanism
is needed. In recent years, rise in antimicrobial resistance in
clinical strains is a serious concern as it hampers outbreak
control policies [10, 19, 35].Thus, antimicrobial resistance can
increase the outbreak size, duration, and case fatality rates.
Continued monitoring of antimicrobial susceptibility as well
as strain-tracking is important in adapting policies for cholera
control at national and global levels.
Nucleotide Sequence Accession Numbers
The GenBank accession numbers for the [ctxB] sequences of
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JX846971, JX846972, JX846973, JX846974, and JX846975,
respectively.
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